EPS +38% to $1.16.
Revenue +4% to $3.87B, above consensus of $3.85B.
Fresenius suffered its first fall in full-year net profit in 12 years as income slipped 6% to $1.11B.
The company predicted that net profit would drop further in 2014, to $1-1.05B, amid cuts in U.S. healthcare budgets. Consensus is for $1.19B. (PR)